C09996756 / invoice 10000
Species:CANINE
Breed:Golden Retriever
Age (years):3
Diagnosis or signs:cytopoint for itchy skin
Consult notes
Pruritis Verified: YES HISTORY Presenting for: 2-year-old female dog presented for paw chewing that started a couple of weeks ago Historical Conditions: Previous episodes of pruritic skin disease starting last year, ear issues, ( see Cowes hx) Diet: Previously fed chicken-based diet, now using quality brands Skin: Sudden onset of allergic skin disease last year, current paw chewing for approximately 2 weeks, Current Meds: Previously treated with Cytopoint with good response EXA Integumentary: Skin condition no lesions despite chewing behaviour, no secondary infection present ASSESSMENT Allergic skin disease - Environmental allergies likely given seasonal pattern and good response to Cytopoint. Food allergy less likely given lack of gastrointestinal symptoms PLAN New Meds/Tx: - Cytopoint 40mg dose administered today Additional Discussion: - Discussed environmental allergen management through reduced exposure - Food trial option discussed involving 6-week trial with novel protein (crocodile and tapioca) - would require elimination of all treats and other foods - Regular bathing of feet recommended to reduce allergen load using mild shampoo - Seasonal treatment approach discussed - can discontinue Cytopoint during winter months if symptoms resolve - Desexing quote provided at $980 given patient's size over 30kg - Some dogs may outgrow allergies, otherwise lifelong management typically required
Animal clinical history (3 most recent)
2026-03-06T00:00:00Z 15:04:00
Pruritis Verified: YES HISTORY Presenting for: 2-year-old female dog presented for paw chewing that started a couple of weeks ago Historical Conditions: Previous episodes of pruritic skin disease starting last year, ear issues, ( see Cowes hx) Diet: Previously fed chicken-based diet, now using quality brands Skin: Sudden onset of allergic skin disease last year, current paw chewing for approximately 2 weeks, Current Meds: Previously treated with Cytopoint with good response EXA Integumentary: Skin condition no lesions despite chewing behaviour, no secondary infection present ASSESSMENT Allergic skin disease - Environmental allergies likely given seasonal pattern and good response to Cytopoint. Food allergy less likely given lack of gastrointestinal symptoms PLAN New Meds/Tx: - Cytopoint 40mg dose administered today Additional Discussion: - Discussed environmental allergen management through reduced exposure - Food trial option discussed involving 6-week trial with novel protein (crocodile and tapioca) - would require elimination of all treats and other foods - Regular bathing of feet recommended to reduce allergen load using mild shampoo - Seasonal treatment approach discussed - can discontinue Cytopoint during winter months if symptoms resolve - Desexing quote provided at $980 given patient's size over 30kg - Some dogs may outgrow allergies, otherwise lifelong management typically required
2026-03-03T00:00:00Z 12:38:00
hx received from Cowes Vet
2026-02-25T00:00:00Z 21:08:00
A/h ingestion of half a nappy approx 1 hr before clinic admission. Induce emesis with apomorphine Vomited large volume of food including chewed nappy material. Metomide s/c
Previous claim history (14)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2025-11-17 | C9498828 | OTITIS EXTERNA |
| 2025-11-17 | C9498828 | TORN DEW CLAW |
| 2025-11-11 | C9472973 | TORN DEW CLAW |
| 2025-11-11 | C9472973 | EAR INFECTION |
| 2025-11-03 | C9446470 | BROKEN NAIL |
| 2025-10-20 | C9376436 | HYPERSENSITIVITY DISORDER (ALLERGY) |
| 2025-09-10 | C9205807 | HYPERSENSITIVITY DISORDER (ALLERGY) |
| 2025-07-31 | C9035877 | ATOPY |
| 2025-03-12 | C8442574 | EAR INFECTION |
| 2025-01-29 | C8260225 | HISTIOCYTOMA (CUTANEOUS, SKIN) |
| 2024-11-15 | C7952824 | VACCINATIONS OR HEALTH CHECKS |
| 2024-08-14 | C7594632 | SKIN CONDITIONS |
| 2024-08-14 | C7622815 | SKIN CONDITIONS |
| 2023-12-28 | C6716036 | INTOXICATION (POISONING), PLANT - GRAPE/RAISIN |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_skin_medication_-_cytopoint | 210.10 | 2026-03-06 | — |
| 20000 | tstarc_consultation | 123.00 | 2026-03-06 | — |
UPM+
- DG02339HYPERSENSITIVITY DISORDER (ALLERGY)DSTP_skin_-_allergic_disorder
Variant (sleepy_king)
HYPERSENSITIVITY DISORDER (ALLERGY)
DSTP_skin_-_allergic_disorder
Conf: 0.980
Threshold: 0.38
Above: ✓
Correct?